Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP:: Kinetics, nicotine effect, and toxicity

被引:47
作者
Ding, YS [1 ]
Molina, PE
Fowler, JS
Logan, J
Volkow, ND
Kuhar, MJ
Carroll, FI
机构
[1] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA
[2] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
关键词
nicotinic acetylcholine receptors; epibatidine; fluorine-18; PET; nicotine; toxicity;
D O I
10.1016/S0969-8051(98)00070-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have previously shown that [F-18]norchlorofluoroepibatidine ([F-18]NFEP) would be an ideal radiotracer for positron emission tomography (PET) imaging of nicotinic acetylcholine receptors (nAChR); however, its high toxicity is a limiting factor for human studies. We, therefore, synthesized its N-methyl derivative ([F-18]N-Me-NFEP) and carried out comparative studies. The distribution volumes for different brain regions were higher for [F-18]N-Me-NFEP than those for [F-18]NFEP (average: 52.5 +/- 0.9 vs. 36.4 +/- 0.7 for thalamus), though the distribution volume (DV) ratios were similar (3.93 +/- 0.27 vs. 3.65 +/- 0.19 for thalamus to cerebellum). Treatment with nicotine reduced the binding of both radiotracers. Toxicology studies in awake rats showed that N-methyl-NFEP has a lower mortality (0 vs. 30%) and smaller effect on plasma catecholamines than NFEP at a dose of 1.5 mu g/kg, However, marked alterations in cardiorespiratory parameters were observed after injection of N-methyl-NFEP (0.5 mu g/kg, IV) to an awake dog, Our results suggest that although the binding characteristics of [F-18]NFEP and [F-18]N-Me-NFEP appear to be ideally suited for PET imaging studies of the human brain, their relatively small safety margin will limit their use in humans. NUCL MED BIOL 26;1:139-148, 1999. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 40 条
  • [21] In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronorchloroepibatidine in rodent and human brain
    Gatley, SJ
    Ding, YS
    Brady, D
    Gifford, AN
    Dewey, SL
    Carroll, FI
    Fowler, JS
    Volkow, ND
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (05) : 449 - 454
  • [22] HALLADAY MW, 1997, J MED CHEM, V40, P4169
  • [23] Horti A, 1996, J LABELLED COMPD RAD, V38, P355, DOI 10.1002/(SICI)1099-1344(199604)38:4<355::AID-JLCR842>3.0.CO
  • [24] 2-3
  • [25] EFFECTS OF ACUTE SUBCUTANEOUS NICOTINE ON ATTENTION, INFORMATION-PROCESSING AND SHORT-TERM-MEMORY IN ALZHEIMERS-DISEASE
    JONES, GMM
    SAHAKIAN, BJ
    LEVY, R
    WARBURTON, DM
    GRAY, JA
    [J]. PSYCHOPHARMACOLOGY, 1992, 108 (04) : 485 - 494
  • [26] GRAPHICAL ANALYSIS OF REVERSIBLE RADIOLIGAND BINDING FROM TIME ACTIVITY MEASUREMENTS APPLIED TO [N-C-11-METHYL]-(-)-COCAINE PET STUDIES IN HUMAN-SUBJECTS
    LOGAN, J
    FOWLER, JS
    VOLKOW, ND
    WOLF, AP
    DEWEY, SL
    SCHLYER, DJ
    MACGREGOR, RR
    HITZEMANN, R
    BENDRIEM, B
    GATLEY, SJ
    CHRISTMAN, DR
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1990, 10 (05) : 740 - 747
  • [27] METHYLLYCACONITINE AND (+)-ANATOXIN-A DIFFERENTIATE BETWEEN NICOTINIC RECEPTORS IN VERTEBRATE AND INVERTEBRATE NERVOUS SYSTEMS
    MACALLAN, DRE
    LUNT, GG
    WONNACOTT, S
    SWANSON, KL
    RAPOPORT, H
    ALBUQUERQUE, EX
    [J]. FEBS LETTERS, 1988, 226 (02) : 357 - 363
  • [28] MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268
  • [29] MARKS MJ, 1985, J PHARMACOL EXP THER, V235, P619
  • [30] Histaminergic contribution to the metabolic effects of neuroglucopenia
    Molina, PE
    Williams, P
    Abumrad, NN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (06) : R1918 - R1924